Japan Lifeline Co Ltd
TSE:7575
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
970
1 342
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Japan Lifeline Co Ltd
Japan Lifeline Co Ltd
Cost of Revenue
Japan Lifeline Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Japan Lifeline Co Ltd
TSE:7575
|
Cost of Revenue
-¥20.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Terumo Corp
TSE:4543
|
Cost of Revenue
-¥456.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-7%
|
|
|
Olympus Corp
TSE:7733
|
Cost of Revenue
-¥319.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
Sysmex Corp
TSE:6869
|
Cost of Revenue
-¥228.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
|
Nihon Kohden Corp
TSE:6849
|
Cost of Revenue
-¥110.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
JEOL Ltd
TSE:6951
|
Cost of Revenue
-¥103.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
Japan Lifeline Co Ltd
Glance View
Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. The company is headquartered in Shinagawa-Ku, Tokyo-To and currently employs 1,167 full-time employees. The firm is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
See Also
What is Japan Lifeline Co Ltd's Cost of Revenue?
Cost of Revenue
-20.8B
JPY
Based on the financial report for Jun 30, 2024, Japan Lifeline Co Ltd's Cost of Revenue amounts to -20.8B JPY.
What is Japan Lifeline Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%
Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for Japan Lifeline Co Ltd have been 3% over the past three years , -2% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
